KP Tissue Market Risk Adjusted Performance
| KPTSF Stock | | | USD 7.98 0.03 0.38% |
This module presents the Market Risk Adjusted Performance indicator for KP Tissue using available market inputs. The underlying data comes from exchange-reported trading records. Coverage differences may occur across instruments and market segments. This dataset is part of a broader indicator framework including
Equity Screeners. KP Tissue has a market cap of 76.14 M, ROE of -7.16%. Use
Correlation Analysis to view allocation positioning. Current allocation data is available for review. The summary draws on available position and value data. All figures are presented for informational review and are not prescriptive. This includes a position in KP Tissue. The allocation reflects this within the position set. Each holding is sized according to the methodology applied to the portfolio. This summary reflects available observations without forecasting intent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
KP Tissue has current Market Risk Adjusted Performance of 0.9963.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.9963 | |
| ER[a] | = | Expected return on investing in KP Tissue |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
KP Tissue ranks
third among pink sheets in market risk adjusted performance across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set at roughly
5.56 Maximum Drawdown per unit of Market Risk Adjusted Performance. KP Tissue carries a
5.56 x Maximum Drawdown-to-Market Risk Adjusted Performance ratio
Other Technical Indicators